Leukemias

Leukemia is a cancer that develops in the bone marrow where blood cells are made.

Programs + Services


Blood and Marrow Transplant Program

The Blood and Marrow Transplant Program at Floating Hospital in Boston provides hematopoietic cell transplants for children with cancer and blood disorders.
More information about programs and services


Leukemias and Lymphomas Program

The specialists at the Floating Hospital for Children have expertise treating childhood leukemia and lymphoma. Learn more and request an appointment.
More information about programs and services

Doctors + Care Team

Jason Law, MD

Jason Law, MD

Accepting New Patients

Title(s): Interim Chief, Pediatric Hematology Oncology; Site Principal Investigator, Children’s Oncology Group and Neuroblastoma Medulloblastoma Translational Research Consortium Trials; Director, Pediatric Bone Marrow Transplantation; Assistant Professor, Tufts University School of Medicine
Department(s): Pediatrics, Pediatric Hematology/Oncology
Appt. Phone: 617-636-5535
Fax #: 617-636-7738

Pediatric hematology, oncology, bone marrow transplant

View Full Profile for Jason Law, MD

Blythe G.  Thomson, MD

Blythe G. Thomson, MD

Accepting New Patients

Title(s): Pediatric Hematologist/Oncologist
Department(s): Pediatrics, Pediatric Hematology/Oncology
Appt. Phone: 617-636-5535
Fax #: 617-636-7738

Pediatric Hematology/Oncology

View Full Profile for Blythe G. Thomson, MD

Cathy G. Rosenfield, MD

Cathy G. Rosenfield, MD

Accepting New Patients

Title(s): Co-Director, Tufts University School of Medicine Hematology Course; Associate Clinical Professor, Tufts University School of Medicine
Department(s): Pediatrics, Pediatric Hematology/Oncology
Appt. Phone: 617-636-5535
Fax #: 617-636-7738

Hemophilia and other bleeding disorders, prothrombotic disorders, sickle cell and other hemoglobinopathies, general hematology

View Full Profile for Cathy G. Rosenfield, MD

Hannah Fassel, MD

Hannah Fassel, MD

Accepting New Patients

Title(s): Hematologist/Oncologist; Assistant Professor, Tufts University School of Medicine
Department(s): Pediatrics, Hematology/Oncology
Appt. Phone: 617-636-5535
Fax #: 617-636-7738

Anemia, bleeding disorders, thrombosis, general hematology, and childhood cancers such as leukemia and lymphoma.

View Full Profile for Hannah Fassel, MD

Laura M.  Wiltsie, DO

Laura M. Wiltsie, DO

Accepting New Patients

Title(s): Pediatric Hematologist/Oncologist
Department(s): Pediatrics, Hematology/Oncology
Appt. Phone: 617-636-5535
Fax #: 617-636-7738

Solid tumors, brain tumors

View Full Profile for Laura M. Wiltsie, DO

Michael Kelly, MD, MPH, MS

Michael Kelly, MD, MPH, MS

Title(s): Associate Clinical Professor, Tufts University School of Medicine
Department(s): Pediatrics, Pediatric Hematology/Oncology
Appt. Phone: 617-636-5535
Fax #: 617-636-7738

Childhood cancers including leukemia, lymphoma and solid tumors, anemia and bleeding disorders, thrombosis

View Full Profile for Michael Kelly, MD, MPH, MS

Tishi Shah, MD

Tishi Shah, MD

Accepting New Patients

Title(s): Attending Physician, Pediatric Hematology Oncology; Professor, Tufts University School of Medicine
Department(s): Pediatrics, Pediatric Hematology/Oncology
Appt. Phone: 617-636-5535
Fax #: 617-636-7738

Pediatric hematology oncology, vascular anomalies

View Full Profile for Tishi Shah, MD

Research + Clinical Trials


International Phase 3 trial in Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) testing imatinib in combination with two different cytotoxic chemotherapy backbones. 

This randomized phase III trial studies how well imatihib mesylate and combination chemotherapy work in treating patients with newly diagnosed Philadelphia chromosome positive acute lymphoblastic leukemia. Imatinib mesylate may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving imatinib mesylate and combination chemotherapy may work better in treating patients with Philadelphia chromosome positive acute lymphoblastic leukemia.
More information about research and clinical trials